A
Amylyx Pharmaceuticals (AMLX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Amylyx Pharmaceuticals (AMLX)
Amylyx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing therapies for treatment paradigm for amyotrophic lateral sclerosis (ALS), and range of neurodegenerative diseases by keeping neurons alive. The Comp... Read more
- USD4.51
- USD4.82
- USD4.41
- USD7.27
- 32.10%
- 87M
- 989.96k
- 1.05M
- 474M
- 1.58
- 143.90%
Stock News
5 hours ago
Orion S.A. (OEC) Q1 2025 Earnings Call Transcript
SeekingAlpha
5 hours ago
Invesco Growth And Income Fund Q1 2025 Commentary
SeekingAlpha
6 hours ago
Transocean Stock Is Dirt-Cheap Thanks To Trump's Tariffs
SeekingAlpha
6 hours ago
Zurich Insurance: Good Operating Performance Seems To Be Priced-In Following Q1 Sales Update
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
